bpc-157 unapproved new drug fda BPC 157 Banned: Key Facts on the Latest Decision fda warning bpc-157 unapproved peptide

The best spot is the lower abdominal area, roughly between the hip bones and two inches below the navel

Standard / Gradual Approach There is no titration schedule for Dihexa in humans, because human absorption, metabolism, and the therapeutic window are simply unknown

Discard if visibly particulate or discolored

2026 Milestone The human trial the field has been waiting for February 2026 First Properly Designed Randomised Controlled Trial Now Recruiting Hudson Biotech began recruiting for the first randomised, placebo-controlled, blinded trial of BPC-157 in humans in February 2026 a Phase 2 study that represents the pivotal transition from preclinical to clinical evidence